NeuroSense Therapeutics Correlations
NRSNW Stock | USD 0.25 0.13 34.21% |
The current 90-days correlation between NeuroSense Therapeutics and Neurosense Therapeutics is -0.06 (i.e., Good diversification). The correlation of NeuroSense Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
NeuroSense Therapeutics Correlation With Market
Good diversification
The correlation between NeuroSense Therapeutics Ltd and DJI is -0.15 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NeuroSense Therapeutics Ltd and DJI in the same portfolio, assuming nothing else is changed.
NeuroSense |
Moving against NeuroSense Stock
0.61 | GNFT | Genfit | PairCorr |
0.49 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.46 | VALN | Valneva SE ADR | PairCorr |
0.44 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
0.42 | ERNA | Eterna Therapeutics | PairCorr |
0.4 | IMAB | I Mab | PairCorr |
0.33 | SLS | Sellas Life Sciences | PairCorr |
0.32 | LLY | Eli Lilly | PairCorr |
0.49 | RANI | Rani Therapeutics | PairCorr |
0.48 | AMGN | Amgen Inc | PairCorr |
0.41 | MRVI | Maravai Lifesciences | PairCorr |
0.41 | ABBV | AbbVie Inc | PairCorr |
0.39 | ALVO | Alvotech | PairCorr |
0.37 | MBIO | Mustang Bio | PairCorr |
0.35 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.31 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
0.31 | REGN | Regeneron Pharmaceuticals | PairCorr |
0.53 | TFFP | Tff Pharmaceuticals | PairCorr |
0.51 | AQST | Aquestive Therapeutics | PairCorr |
0.45 | SNDL | SNDL Inc | PairCorr |
0.44 | AVDL | Avadel Pharmaceuticals | PairCorr |
0.41 | SYRE | Spyre Therapeutics | PairCorr |
0.4 | TCRX | Tscan Therapeutics | PairCorr |
Related Correlations Analysis
0.07 | 0.3 | 0.14 | 0.5 | NRSN | ||
0.07 | -0.32 | -0.28 | -0.55 | KTTAW | ||
0.3 | -0.32 | 0.16 | 0.59 | GOVXW | ||
0.14 | -0.28 | 0.16 | 0.19 | NLSPW | ||
0.5 | -0.55 | 0.59 | 0.19 | CINGW | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between NeuroSense Stock performing well and NeuroSense Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NeuroSense Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NRSN | 3.34 | (0.59) | 0.00 | (0.64) | 0.00 | 5.83 | 25.07 | |||
KTTAW | 21.16 | 5.84 | 0.24 | 4.42 | 16.14 | 62.34 | 141.61 | |||
GOVXW | 10.59 | (0.91) | 0.00 | (0.27) | 0.00 | 25.00 | 55.63 | |||
NLSPW | 22.60 | 4.06 | 0.13 | (0.78) | 18.96 | 90.00 | 190.13 | |||
CINGW | 10.32 | 0.40 | 0.01 | (0.16) | 13.08 | 17.00 | 81.96 |
NeuroSense Therapeutics Corporate Management
Yael Barak | VP Compliance | Profile | |
Ferenc Tracik | Chief Officer | Profile | |
Or Eisenberg | Chief Officer | Profile | |
Alon BenNoon | CEO CoFounder | Profile | |
Hagit Binder | Chief Officer | Profile | |
Oron DVM | Chief Officer | Profile | |
Ferenc MD | Chief Officer | Profile |